NEW YORK (360Dx) – Bio-Rad Laboratories said after the close of the market on Monday that the US Food and Drug Administration has cleared the company's IH-500 automated random access system for blood typing and screening.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
This webinar will provide an overview of polygenic risk scores, which aggregate dozens of genetic variants that have been linked to disease risk in genome-wide association studies (GWAS) into a single score.
This webinar will discuss cell-free DNA prenatal screening in the era of genome-wide sequencing and factors influencing the clinical utility of expanded noninvasive prenatal testing (NIPT) menus.